Intellia Therapeutics, Inc.
NTLAHealthcareBiotechnology
市值
$1.97B
CEO
John Leonard
员工数
403
行业
Biotechnology
上市日期
2016-05-06
收录人数
16
近期高管变动
08/07离任Dr. David Lebwohl, M.D. Executive Vice President and Chief Medical Officer06/12上任William Chase class III director06/12上任Georgia Keresty, Ph.D., M.P.H. class III director06/12上任John M. Leonard, M.D. class III director01/10离任Laura Sepp-Lorenzino, Ph.D. Executive Vice President and Chief Scientific Officer (CSO)01/10职务变更Laura Sepp-Lorenzino, Ph.D. Special Advisor to the Chief Executive Officer01/10上任Birgit Schultes, Ph.D. Executive Vice President and CSO06/26上任Edward Dulac Executive Vice President and Chief Financial Officer, treasurer and principal financial officer
数据暂不可用